Following the establishment of stable shRNA-viral transfections in 786-O and 769-P cell lines, a series of functional experiments revealed that RELT knockdown mitigates the malignant biological behavior of clear cell renal cell carcinoma (ccRCC), whereas RELT overexpression promotes ccRCC progression. Here, RELT is linked to nonpapillary renal cell carcinoma.